Abstract:Background: The brain atrophy in individual Alzheimer's disease (AD) patients includes not only specific atrophy from AD pathology, but also atrophy induced by normal aging and cerebral vascular diseases. Although medial temporal lobe atrophy (MTA) together with CSF biomarkers is suggested to be the most important diagnostic markers for AD, it may not be specific. The current method of choice to measure MTA has been volumetric measurement based on 3D magnetic resonance imaging (MRI), but this complicated method has not been implemented clinically. Female sex has been suggested to be a risk factor for AD. The left hippocampus may be more vulnerable in AD. Atrophy of hippocampus has also been found to emerge in healthy adults, along with increased age. Purposes: To investigate whether simple Computerized Tomography (CT) linear measurements of brain could be of value in AD work-up; to create a normative database of hippocampus volume in our large population-based study and to examine if there is an acceleration of hippocampal atrophy in normal aging; to examine the hippocampal and entorhinal cortex volumes in relation to vascular risk factors. Material and Methods: In the CT study (Papers 1&2), 59 controls, 162 pure AD, and 86 AD with minor cerebrovascular changes (CVC) between the ages of 52 and 94 years were recruited from the Malmo Alzheimer Study. Abeta42, T-tau and P-tau in CSF were examined. CT linear measurements were performed, which included temporal horn ratio and suprasellar cistern ratio that reflect MTA. In the MRI study (Papers 3&4), 544 healthy non-demented subjects (aged 60-97 years) were recruited from the Swedish National study of Aging and Care in Kungsholmen (SNAC-K). Hippocampal formation and entorhinal cortex were manually delineated. Semi-automatic tools were used to access the volume of 3rd, lateral ventricle and intracranial volume (ICV). Vascular risk factors were collected. Results: In the CT study (Papers 1&2), temporal horn ratio and suprasellar cistern ratio were the atrophy factors that contributed most significantly to the diagnoses with correct AD classification of 90.2%. The correct classification of AD+CVC from controls increased from 79.5% (only CSF biomarkers) to 84.6% (combined CT measurements with CSF biomarkers). However, little was changed in the pure AD group. In the MRI study (Papers 3&4), The normalized volumes of hippocampus in males were smaller than that in females. The right hippocampus was larger than the left. The rate of aging atrophy trend (AAT) for the expansion of ventricles was larger than the estimated hippocampal shrinkage. The age point (72y) was shown to represent the time when the acceleration of AAT in hippocampus starts in normal aging. The score of vascular risk factors was significantly associated with reduced volumes of hippocampus and entorhinal cortex only among men. Conclusions: CT linear measurements could be of value in work-up of AD patients. Combined with the CT measure of MTA, the specificity of CSF biomarkers can be increased, but only in AD+CVC. In a non-demented elderly population, the females were more vulnerable to hippocampal atrophy. An acceleration of hippocampal atrophy may emerge and start around 72 years of age. An increasing burden of vascular risk factors is associated with reduced volume of hippocampus and entorhinal cortex.

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.

Memory Tests Predict the Change of Hippocampus Topography in Mild Cognitive Impairment Patients

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Atrophy rates accelerate in amnestic mild cognitive impairment

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

The relationship between hippocampal changes in healthy aging and Alzheimer's disease: a systematic literature review

Brain MRI and CT Morphology in Healthy Aging and Alzheimer's Disease

Atrophy of hippocampal subfields relates to memory decline during the pathological progression of Alzheimer's disease

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer's disease spectrum

Hippocampal Atrophy Subtypes of Alzheimer's Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications

Differential atrophy along the longitudinal hippocampal axis in Alzheimer's disease for the Alzheimer's Disease Neuroimaging Initiative

Longitudinal Trajectory of Amyloid-related Hippocampal Subfield Atrophy in Nondemented Elderly.

Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age

Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer's Disease: A Structural Imaging Study.

A Longitudinal Study of Atrophy in Amnestic Mild Cognitive Impairment and Normal Aging Revealed by Cortical Thickness.

Progressive Volume Atrophy in Hippocampal Subfields and the Correlation with Cognition in Alzheimer’s Disease and Mild Cognitive Impairment

P2‐049: Reduced Functional Hippocampal Connectivity Associates with Gray Matter Volume Loss in Mild Cognitive Impairment and Alzheimer's Disease Subjects

Convergence of Accelerated Brain Volume Decline in Normal Aging and Alzheimer's Disease Pathology

Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls